A detailed history of Pekin Hardy Strauss, Inc. transactions in Dyadic International Inc stock. As of the latest transaction made, Pekin Hardy Strauss, Inc. holds 47,020 shares of DYAI stock, worth $92,629. This represents 0.01% of its overall portfolio holdings.

Number of Shares
47,020
Previous 47,020 -0.0%
Holding current value
$92,629
Previous $69,000 30.43%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

SELL
$1.52 - $2.04 $3,207 - $4,304
-2,110 Reduced 4.29%
47,020 $75,000
Q4 2022

Feb 13, 2023

SELL
$1.18 - $2.32 $2,489 - $4,895
-2,110 Reduced 4.12%
49,130 $60,000
Q1 2022

May 13, 2022

SELL
$3.01 - $4.81 $6,351 - $10,149
-2,110 Reduced 3.96%
51,240 $154,000
Q4 2019

Feb 12, 2020

SELL
$5.02 - $6.66 $40,200 - $53,333
-8,008 Reduced 13.05%
53,350 $276,000
Q2 2019

Aug 12, 2019

BUY
$3.15 - $6.95 $193,277 - $426,438
61,358 New
61,358 $384,000

Others Institutions Holding DYAI

About DYADIC INTERNATIONAL INC


  • Ticker DYAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,423,100
  • Market Cap $56M
  • Description
  • Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...
More about DYAI
Track This Portfolio

Track Pekin Hardy Strauss, Inc. Portfolio

Follow Pekin Hardy Strauss, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pekin Hardy Strauss, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pekin Hardy Strauss, Inc. with notifications on news.